首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

2126780

體外受精設備市場：按產品類型、治療方法、最終用戶和地區分類

In Vitro Fertilization Devices Market, By Product Type,By Procedure, By End User, By Geography

出版日期: 2026年08月11日 | 出版商:

Coherent Market Insights | 英文 257 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

體外受精（IVF）設備市場預計到2026年將達到14.561億美元，預計2033年將達到26.617億美元。預計從2026年到2033年，該市場將以9.0%的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	14.561億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	9.00	2033年市場規模預測：	26.617億美元

該市場正在經歷重大變革，這主要是由於不孕症的盛行率不斷上升、高齡產婦生育的趨勢、輔助生殖技術 (ART) 的日益普及以及全球範圍內專業不孕症診所和體外受精 (IVF) 中心的擴張。

體外受精（IVF）設備包括用於處理配子、受精、胚胎培養、監測、冷凍保存、儲存以及相關輔助生殖技術流程的專用實驗室設備、儀器、培養基、儲存系統和耗材。該市場涵蓋廣泛的產品，包括培養箱、IVF耗材、培養基、倒置顯微鏡、層流系統、胚胎冷凍設備和冷凍保存槽。治療數量的不斷成長推動了對整個IVF流程中使用的高成本實驗室設備和耗材的持續需求。

為了提高胚胎培養的穩定性、流程標準化、可追溯性和治療效果，生育治療中心正擴大採用技術先進的實驗室系統。延時胚胎監測、人工智慧輔助胚胎評估、冷凍保存、全胚胎冷凍策略、胚胎著床前遺傳學檢測以及數位體外受精實驗室技術的日益普及，進一步推動了對先進體外受精設備和實驗室基礎設施的需求。預計到2026年，北美將佔全球市場佔有率的約38.5%，而亞太地區預計將在預測期內成為成長最快的區域市場。

市場動態

由於不孕症盛行率上升、生育年齡偏大、體外受精（IVF）和其他輔助生殖技術的使用增加，以及全球生育診所數量的成長，市場呈現強勁成長勢頭。世界衛生組織（WHO）的數據顯示，全球約有17.5%的成年人口，即六分之一的人口面臨不孕不育問題，這意味著有大量潛在人群需要不孕症相關的診斷和治療。

輔助生殖技術（ART）數量的不斷成長直接推動了胚胎培養箱、倒置顯微鏡、顯微操作系統、冷凍保存系統、胚胎冷凍裝置、培養基以及其他體外受精（IVF）實驗室耗材的使用量增加。專業的IVF中心是主要的需求來源，因為它們將胚胎培養、卵胞漿內單一精子注射（ICSI）、冷凍保存、胚胎移植以及配子/胚胎儲存整合在一個專門的實驗室環境中。預計到2026年，IVF中心將佔據約65.0%的市場佔有率，這反映了這些機構集中進行ART手術和配備專用設備。

技術進步是影響市場發展的另一個關鍵因素。體外受精（IVF）實驗室正從傳統的獨立設備轉向日益自動化、數位化整合和數據驅動的實驗室生態系統。人工智慧驅動的胚胎分級、延時培養箱、數位顯微鏡、胚胎成像系統、電子實驗室技術和決策支援平台的廣泛應用，提高了胚胎評估的準確性和實驗室工作流程的效率。同時，「全胚胎冷凍」策略和冷凍胚胎移植的日益普及，也推動了對玻璃化冷凍解決方案、胚胎冷凍設備、低溫儲存設備及相關耗材的需求成長。

在一些市場，生育治療保險覆蓋範圍的擴大以及政府和雇主提供的生殖醫療給付的增加，正在改善患者獲得體外受精（IVF）服務的機會。然而，IVF手術的高昂費用以及部分國家有限的保險覆蓋範圍仍然限制了患者獲得治療的機會，進而也限制了醫療設備的供應。因此，市場參與企業越來越關注能夠提高檢查室效率、可靠性、臨床效果、可追溯性和成本效益的技術。

本次調查的主要特點

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據公司概況、產品系列、主要亮點、財務績效和策略等參數，介紹了體外受精設備市場主要參與者的概況。
本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品類型升級、市場擴張和行銷策略做出明智的決策。
體外受精設備市場報告的目標受群眾外包括該行業的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過利用體外受精設備市場分析中使用的各種策略矩陣來簡化決策過程。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第8章競爭情勢

熱圖分析
市佔率分析
公司簡介
- Vitrolife AB
- CooperSurgical Inc.
- Thermo Fisher Scientific Inc.
- COOK MEDICAL INC.
- Genea Biomedx
- Merck KGaA
- OvaScience, Inc.
- JXTG Holdings, Inc.
- Progyny, Inc.
- Oxford Gene Technology Inc.
- EMD Serono, Inc.
- Irvine Scientific
分析師意見

第9章

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI887

In Vitro Fertilization Devices Market is estimated to be valued at USD 1,456.1 Mn in 2026 and is expected to reach USD 2,661.7 Mn by 2033, growing at a compound annual growth rate (CAGR) of 9.0% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 1,456.1 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	9.00%	2033 Value Projection:	USD 2,661.7 Mn

The market is undergoing significant transformation, mainly driven by the rising prevalence of infertility, increasing trend of delayed parenthood, growing adoption of assisted reproductive technologies (ART), and expansion of specialized fertility clinics and IVF centers worldwide.

In vitro fertilization devices comprise specialized laboratory equipment, instruments, media, storage systems, and consumables used for gamete handling, fertilization, embryo culture, monitoring, cryopreservation, storage, and associated assisted reproductive procedures. The market includes a wide range of products such as incubators, IVF consumables, culture media, inverted microscopes, laminar air flow instruments, embryo freezers, and embryo cryogenic storage tanks. Increasing treatment volumes are generating recurring demand for both capital-intensive laboratory equipment and consumable products used throughout the IVF workflow.

Fertility centers are increasingly adopting technologically advanced laboratory systems to improve embryo-culture stability, workflow standardization, traceability, and treatment outcomes. The growing adoption of time-lapse embryo monitoring, AI-assisted embryo assessment, cryopreservation, freeze-all strategies, preimplantation genetic testing, and digital IVF laboratory technologies is further supporting demand for sophisticated IVF devices and laboratory infrastructure. North America is estimated to account for approximately 38.5% of the global market in 2026, while Asia Pacific is expected to emerge as the fastest-growing regional market during the forecast period.

Market Dynamics

The market is witnessing strong momentum owing to the increasing prevalence of infertility, delayed parenthood, rising utilization of IVF and other assisted reproductive technologies, and expansion of fertility clinics worldwide. According to the World Health Organization, approximately 17.5% of the global adult population, or around one in six people, experience infertility, indicating a substantial underlying population requiring fertility-related diagnosis and treatment.

Growing ART procedure volumes are directly increasing the utilization of embryo incubators, inverted microscopes, micromanipulation systems, cryogenic storage systems, embryo freezers, culture media, and other IVF laboratory consumables. Specialized IVF centers represent a major source of demand as they integrate embryo culture, ICSI, cryopreservation, embryo transfer, and gamete and embryo storage within dedicated laboratory environments. The IVF center segment is estimated to account for approximately 65.0% of the market in 2026, reflecting the concentration of ART procedures and specialized equipment within these facilities.

Technological advancement is another important factor shaping market development. IVF laboratories are transitioning from conventional standalone equipment toward increasingly automated, digitally integrated, and data-driven laboratory ecosystems. The growing use of AI-assisted embryo grading, time-lapse incubators, digital microscopes, embryo imaging systems, electronic laboratory technologies, and decision-support platforms is improving embryo assessment and laboratory workflow efficiency. In parallel, increasing adoption of freeze-all IVF strategies and frozen embryo transfers is strengthening demand for vitrification solutions, embryo freezers, cryogenic storage equipment, and associated consumables.

Improving fertility-treatment coverage and expanding government and employer-supported reproductive-health benefits are also improving patient access to IVF services in several markets. At the same time, the high cost of IVF treatment procedures and limited reimbursement coverage across several countries continue to restrict treatment accessibility and consequently limit potential device utilization. Market participants are therefore increasingly focusing on technologies that improve laboratory productivity, reliability, clinical outcomes, traceability, and cost efficiency.

Key Features of the Study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the In Vitro Fertilization Devices Market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Vitrolife AB, CooperSurgical Inc., Thermo Fisher Scientific Inc., COOK MEDICAL INC., Genea Biomedx, Merck KGaA, OvaScience, Inc., JXTG Holdings, Inc., Progyny, Inc., and Oxford Gene Technology Inc., EMD Serono,Inc., and Irvine Scientific.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The In Vitro Fertilization Devices Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the In Vitro Fertilization Devices Market

Market Segmentation

By Product Type (Revenue, USD Mn, 2021-2033)
Incubator
IVF consumables
Cultural media
- Cryopreservation media
- Semen processing media
- Embryo culture media
- Ovum processing media
Inverted microscope
Laminar air flow instrument
Embryo freezers
Embryo cryogenic storage tank
By Procedure (Revenue, USD Mn, 2021-2033)
Intra Cytoplasmic Sperm Injection (ICSI)
Embryo Freezing and Frozen Embryo Transfer (FET)
Pre-Implantation Genetic Diagnosis (PGD)
By End User (Revenue, USD Mn, 2021-2033)
Hospitals
Gynecological clinics
IVF center
Clinical research institutes
By Region (Revenue, USD Mn, 2021-2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC
- Israel
- Rest of Middle East
Africa
- South Africa
- Central Africa
- North Africa
Key Players
Vitrolife AB
CooperSurgical Inc.
Thermo Fisher Scientific Inc.
COOK MEDICAL INC.
Genea Biomedx
Merck KGaA
OvaScience, Inc.
JXTG Holdings, Inc.
Progyny, Inc.
Oxford Gene Technology Inc.
EMD Serono,Inc.
Irvine Scientific

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Procedure
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Key Developments
Product Approval
Collaboration/Merge/Acquisition
Regulatory Landscape
PEST Analysis
Porter's Five Forces Analysis
Epidemiology
Robust Pipeline Analysis

4. Global In Vitro Fertilization Devices Market, By Product Type, 2021 - 2033, (USD Million)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Incubator
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
IVF consumables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
Cultural media
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
  - Cryopreservation media
  - Semen processing media
  - Embryo culture media
  - Ovum processing media
Inverted microscope
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
Laminar air flow instrument
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
Embryo freezers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
Embryo cryogenic storage tank
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)

5. Global In Vitro Fertilization Devices Market, By Procedure, 2021 - 2033, (USD Million)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Intra Cytoplasmic Sperm Injection (ICSI)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
Embryo Freezing and Frozen Embryo Transfer (FET)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
Pre-Implantation Genetic Diagnosis (PGD)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)

6. Global In Vitro Fertilization Devices Market, By End User, 2021 - 2033, (USD Million)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
Gynecological clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
IVF center
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
Clinical research institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)

7. Global In Vitro Fertilization Devices Market, By Region, 2021 - 2033, (USD Million)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021-2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Million)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021-2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Million)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021-2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Million)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021-2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Million)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021-2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Million)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021-2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Million)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Heat Map Analysis
Market Share Analysis
Company Profile
- Vitrolife AB
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- CooperSurgical Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Thermo Fisher Scientific Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- COOK MEDICAL INC.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Genea Biomedx
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Merck KGaA
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- OvaScience, Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- JXTG Holdings, Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Progyny, Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Oxford Gene Technology Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- EMD Serono,Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Irvine Scientific
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
Analyst Views